A detailed history of Logan Capital Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Logan Capital Management Inc holds 29,413 shares of NVO stock, worth $2.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
29,413
Previous 29,530 0.4%
Holding current value
$2.5 Million
Previous $4.22 Million 16.92%
% of portfolio
0.15%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

SELL
$119.07 - $145.42 $13,931 - $17,014
-117 Reduced 0.4%
29,413 $3.5 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $25,891 - $30,998
-211 Reduced 0.71%
29,530 $4.22 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $9,292 - $12,368
91 Added 0.31%
29,741 $3.82 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $3,335 - $4,007
-38 Reduced 0.13%
29,650 $3.07 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.35 Million - $2.96 Million
14,844 Added 100.0%
29,688 $2.7 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $14,689 - $17,664
-111 Reduced 0.74%
14,844 $2.36 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $13,126 - $17,322
128 Added 0.86%
14,955 $2.02 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $35,158 - $43,147
369 Added 2.55%
14,827 $1.48 Million
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $154,447 - $182,227
1,496 Added 11.54%
14,458 $1.61 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $41,336 - $49,967
-444 Reduced 3.31%
12,962 $1.44 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $21,668 - $26,460
226 Added 1.71%
13,406 $1.5 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $118,525 - $149,694
1,404 Added 11.92%
13,180 $1.27 Million
Q2 2021

Aug 17, 2021

BUY
$67.66 - $84.76 $484,919 - $607,474
7,167 Added 155.5%
11,776 $986,000
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $309,079 - $349,454
4,609 New
4,609 $311,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.